PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $632,000 | +2.4% | 125,000 | +25.0% | 0.02% | +66.7% |
Q2 2019 | $617,000 | +33.0% | 100,000 | 0.0% | 0.02% | +7.1% |
Q1 2019 | $464,000 | +10.5% | 100,000 | 0.0% | 0.01% | -17.6% |
Q4 2018 | $420,000 | -33.0% | 100,000 | 0.0% | 0.02% | +30.8% |
Q3 2018 | $627,000 | +23.9% | 100,000 | +5.3% | 0.01% | +62.5% |
Q4 2013 | $506,000 | +100.8% | 95,000 | +90.0% | 0.01% | +60.0% |
Q3 2013 | $252,000 | – | 50,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARDSLEY ADVISORY PARTNERS LP | 1,255,000 | $5,823,000 | 1.12% |
Phocas Financial Corp. | 1,146,292 | $5,319,000 | 0.54% |
Worth Venture Partners, LLC | 138,357 | $641,000 | 0.36% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,293,179 | $10,640,000 | 0.34% |
Monashee Investment Management LLC | 240,000 | $1,114,000 | 0.26% |
BKS ADVISORS, LLC | 118,587 | $550,000 | 0.22% |
PINNACLE ASSOCIATES LTD | 1,418,391 | $6,581,000 | 0.15% |
FARALLON CAPITAL MANAGEMENT LLC | 4,200,820 | $19,492,000 | 0.15% |
Fosun International Ltd | 472,580 | $2,174,000 | 0.14% |
CARILLON TOWER ADVISERS, INC. | 3,948,024 | $18,318,000 | 0.13% |